Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE StudyPaul A. Carpenter, Jean‐Hugues Dalle, Bin Cho et al.|Transplantation and Cellular Therapy|2022Cited by 31
Prospective Trial of Ibrutinib for the Treatment of Pediatric Chronic Graft-Versus-Host DiseasePaul A. Carpenter, Jean‐Hugues Dalle, Hyoung Jin Kang et al.|Transplantation and Cellular Therapy|2022Cited by 0